» Authors » Ana Paula Simoes-Wust

Ana Paula Simoes-Wust

Explore the profile of Ana Paula Simoes-Wust including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 312
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zurfluh L, Santos S, Ruppen A, Mosbacher J, Haslinger C, Ochsenbein-Kolble N, et al.
Biomed Pharmacother . 2025 Feb; 184:117919. PMID: 39983434
Preparations of Bryophyllum pinnatum have been used as a well-tolerated treatment of preterm labor, initially in anthroposophic hospitals and, more recently, also in conventional settings. In vitro studies with human...
2.
Huber T, Kruerke D, Haeck T, Weber M, Kroz M, Schlemmer M, et al.
Pharmaceuticals (Basel) . 2024 Nov; 17(11). PMID: 39598334
Background/objectives: spp. preparations are widely used in Anthroposophic Medicine, most often for mental and behavioral disorders, including anxiety. Studies in animals revealed various anxiolytic and neurosedative effects for . We...
3.
Srikantha P, Winterfeld U, Girardin F, Panchaud A, Ochsenbein-Kolble N, Simoes-Wust A
Swiss Med Wkly . 2024 Aug; 154:3751. PMID: 39137375
Aims Of The Study: Limited knowledge exists regarding exposures to non-therapeutic chemicals by women planning to conceive, or during pregnancy or breastfeeding. The Swiss Teratogen Information Service (STIS) provides information...
4.
Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad R, Berlin M, et al.
BMJ Open . 2024 Apr; 14(4):e083550. PMID: 38663923
Objectives: Glucagon-like peptide 1 receptor agonists (GLP1-RA) are indicated for the treatment of type 2 diabetes and more recently for weight loss. The aim of this study was to assess...
5.
Zurfluh L, Duvaud L, Inci N, Potterat O, Simoes-Wust A, Mosbacher J
Planta Med . 2024 Apr; 90(10):757-765. PMID: 38599625
The medicinal plant was previously shown to block oxytocin (OT)-induced signals in myometrial cells, consistent with its tocolytic effect observed in patients. OT activates not only OT receptors but also...
6.
Kuoni S, Steiner R, Saleh L, Lehmann R, Ochsenbein-Kolble N, Simoes-Wust A
Biomed Pharmacother . 2024 Jan; 171:116177. PMID: 38262151
Although uncontrolled hyperglycaemia during pregnancy can cause complications for both the mother and her offspring, pharmacological treatment options for gestational and type 2 diabetes in pregnancy are still limited. Empagliflozin...
7.
Huber T, Kruerke D, Simoes-Wust A
Complement Med Res . 2024 Jan; 31(2):116-123. PMID: 38185101
Background: Bryophyllum preparations are widely used in anthroposophic medicine, most often for mental and behavioural disorders. Three prospective studies have revealed positive effects of Bryophyllum pinnatum on sleep quality, and...
8.
Zurfluh L, Spinelli M, Betschart C, Simoes-Wust A
Front Pharmacol . 2023 Dec; 14:1292919. PMID: 38130407
Dysmenorrhea affects women throughout their reproductive years but there has been a lack of effective and well-tolerated treatment options. Pain symptoms mainly result from inflammatory processes and increased contractile activity...
9.
Kuoni S, Muller D, Simoes-Wust A, Steiner R
J Chromatogr B Analyt Technol Biomed Life Sci . 2023 Aug; 1228:123841. PMID: 37542935
A liquid chromatography - tandem mass spectrometry (LC-MS/MS) method has been developed to simultaneously measure four sodium glucose co-transporter 2 (SGLT2) inhibitors and the transfer marker antipyrine (ANTI) in perfusion...
10.
Spiess D, Abegg V, Chauveau A, Rath J, Treyer A, Reinehr M, et al.
Front Pharmacol . 2023 Apr; 14:1123194. PMID: 37063288
Safe medications for mild mental diseases in pregnancy are needed. Phytomedicines from St. John's wort and valerian are valid candidates, but safety data in pregnancy are lacking. The transplacental transport...